Compare · TMO vs VECO
TMO vs VECO
Side-by-side comparison of Thermo Fisher Scientific Inc (TMO) and Veeco Instruments Inc. (VECO): market cap, price performance, sector, and recent activity on the wire.
Summary
- TMO operates in Industrials, while VECO operates in Technology - the two are in different parts of the market.
- TMO is the larger of the two at $177.93B, about 59.1x VECO ($3.01B).
- Over the past year, TMO is up 14.2% and VECO is up 164.6% - VECO leads by 150.3 points.
- TMO has been more active in the news (9 items in the past 4 weeks vs 1 for VECO).
- TMO has more recent analyst coverage (25 ratings vs 11 for VECO).
- Company
- Thermo Fisher Scientific Inc
- Veeco Instruments Inc.
- Price
- $479.36+2.79%
- $49.87+4.35%
- Market cap
- $177.93B
- $3.01B
- 1M return
- -2.51%
- +47.24%
- 1Y return
- +14.23%
- +164.56%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- 1994
- News (4w)
- 9
- 1
- Recent ratings
- 25
- 11
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Veeco Instruments Inc.
Veeco Instruments Inc., together with its subsidiaries, develops, manufactures, sells, and supports semiconductor and thin film process equipment primarily to make electronic devices worldwide. The company offers laser annealing, ion beam deposition and etch, metal organic chemical vapor deposition, single wafer wet processing and surface preparation, molecular beam epitaxy, and atomic layer deposition and other deposition systems, as well as packaging lithography equipment. Its process equipment systems are used in the production of a range of microelectronic components, including logic, dynamic random-access memory, photonics devices, power electronics, radio frequency filters and amplifiers, thin film magnetic heads, and other semiconductor devices. The company markets and sells its products to integrated device manufacturers and foundries; outsourced semiconductor assembly and test, hard disk drive, and photonics manufacturers; and research centers and universities. Veeco Instruments Inc. was founded in 1945 and is headquartered in Plainview, New York.
Latest TMO
- President & COO Pettiti Gianluca sold $185,064 worth of shares (400 units at $462.66) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 25,051 units (SEC Form 4)
- Thermo Fisher Scientific to Host Investor Day
- Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Thermo Fisher Scientific Reports First Quarter 2026 Results
- AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages
- Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PRECISE-SG100K Singapore to Advance Population-Scale Proteomics
- SEC Form DEFA14A filed by Thermo Fisher Scientific Inc
- SEC Form DEF 14A filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 23, 2026
Latest VECO
- Veeco Announces Date for First Quarter 2026 Financial Results and Conference Call
- Amendment: SEC Form SCHEDULE 13G/A filed by Veeco Instruments Inc.
- SEC Form 4 filed by Miller William John
- SEC Form 4 filed by Kiernan John P
- SEC Form 4 filed by Devasahayam Adrian
- SEC Form 4 filed by Porshnev Peter
- SEC Form 4 filed by Wilkerson Susan
- SEC Form DEFA14A filed by Veeco Instruments Inc.
- SEC Form DEF 14A filed by Veeco Instruments Inc.
- SVP - PRODUCT LINE DEVELOPMENT Devasahayam Adrian converted options into 8,267 shares and covered exercise/tax liability with 3,153 shares, increasing direct ownership by 5% to 115,383 units (SEC Form 4)